As the medical aesthetics industry advances toward greater refinement in 2025, non-surgical contouring of the mandible has become one of the most sought-after non-surgical treatments worldwide. Successful outcomes depend heavily on the selection of advanced injectable fillers that offer optimal support and longevity. As a leading medical aesthetics product supplier, we are pleased to present a clinical case using AOMA Plus a premier hyaluronic acid-based product available through our wholesale of hyaluronic acid programs for jawline enhancement and chin augmentation
Evolving Trends in Facial Contouring: The Shift to Structural Aesthetics
Today' s practitioners recognize that effective facial harmonization involves more than superficial volume replacement. The following trends highlight the sophisticated approach now defining medical aesthetics in 2025:
Trend 1: Combination Therapy for Global Rejuvenation
Modern treatment plans often pair dermal fillers with adjunctive agents such as botulinum toxin for muscular rebalancing, offering comprehensive lower-face rejuvenation through non-surgical treatments.
Trend 2: High-Performance Fillers for Structural Applications
Areas such as the jawline and chin require facial fillers with high elasticity and cohesion. OTESALY Plus meets these demands, making it ideal for chin augmentation and jawline enhancement as part of advanced non-surgical contouring protocols.
Trend 3: Personalized and Natural Outcomes
Patients seek subtle, individualized results—not an overdone look. This shift reinforces the importance of customized injection strategies and premium injectable fillers.
Clinical Case: Jawline and Chin Enhancement with AOMA Plus
Patient Profile
A 38-year-old female presented with mild chin retrusion and loss of jawline definition. She desired a more sculpted lower face but wished to avoid surgery.
Treatment Plan
Product: AOMA Plus (2.0 mL total), a monophasic hyaluronic acid dermal filler supplied through our global wholesale hyaluronic acid fillernetwork.
Technique: Layered injection approach deep structural support plus superficial contouring to achieve natural jawline enhancement and chin augmentation.
Results
Significant improvement in lower facial contour was observed immediately and maintained at 3-month follow-up, with high patient satisfaction. This case underscores the efficacy of high-quality facial fillers in non-surgical contouring.
Professional Considerations: Efficacy and Safety of Modern Injectable Fillers
Benefits of AOMA Plus HA Filler in Facial Contouring
● Provides durable structural support for chin augmentation and jawline enhancement
● Typical longevity of 12–18 months, consistent with high-end dermal fillers
● Enables natural-looking results through precise non-surgical treatments
Safety and Best Practices
As with all injectable fillers, patient safety depends on product quality and injector expertise. We encourage clinics to source facial fillers only from reputable medical aesthetics product supplier partners.
Partner with a Trusted Global Supplier
This clinical success was made possible through the use of AOMA Plus a top-tier product available via our specialized wholesale of hyaluronic acid supply chain. As an established medical aesthetics product supplier, we support aesthetic clinics and distributors worldwide with consistent access to premium dermal fillers and injectable fillers.
Interested in enhancing your treatment offerings?
●Inquire about our wholesale of hyaluronic acid programs
●Request clinical support materials for chin augmentation and jawline enhancement
●Learn more about AOMA Plus and other advanced facial fillers
Conclusion
In 2025, non-surgical contouring continues to drive growth in medical aesthetics. By partnering with a reliable medical aesthetics product supplier and utilizing high-performance injectable fillers such as AOMA Plus, clinics can confidently meet patient demand for safe, effective, and natural-looking non-surgical treatments.
